Your browser doesn't support javascript.
loading
Mode of clinical presentation and delayed diagnosis of Turner syndrome: a single Centre UK study.
Apperley, Louise; Das, Urmi; Ramakrishnan, Renuka; Dharmaraj, Poonam; Blair, Jo; Didi, Mohammed; Senniappan, Senthil.
Afiliación
  • Apperley L; Department of Paediatric Endocrinology, Alder Hey Children's Hospital NHS Trust, Liverpool, UK.
  • Das U; Department of Paediatric Endocrinology, Alder Hey Children's Hospital NHS Trust, Liverpool, UK.
  • Ramakrishnan R; Department of Paediatric Endocrinology, Alder Hey Children's Hospital NHS Trust, Liverpool, UK.
  • Dharmaraj P; Department of Paediatric Endocrinology, Alder Hey Children's Hospital NHS Trust, Liverpool, UK.
  • Blair J; Department of Paediatric Endocrinology, Alder Hey Children's Hospital NHS Trust, Liverpool, UK.
  • Didi M; Department of Paediatric Endocrinology, Alder Hey Children's Hospital NHS Trust, Liverpool, UK.
  • Senniappan S; Department of Paediatric Endocrinology, Alder Hey Children's Hospital NHS Trust, Liverpool, UK.
Article en En | MEDLINE | ID: mdl-29983717
ABSTRACT

BACKGROUND:

Early diagnosis of girls with Turner syndrome (TS) is essential to provide timely intervention and support. The screening guidelines for TS suggest karyotype evaluation in patients presenting with short stature, webbed neck, lymphoedema, coarctation of aorta or ≥ two dysmorphic features. The aim of the study was to determine the age and clinical features at the time of presentation and to identify potential delays in diagnosis of TS.

METHODS:

Retrospective data on age at diagnosis, reason for karyotype analysis and presenting clinical features was collected from the medical records of 67 girls with TS.

RESULTS:

The mean age of diagnosis was 5.89 (±5.3) years ranging from pre-natal to 17.9 years (median 4.6 years). 10% were diagnosed antenatally, 16% in infancy, 54% in childhood (1-12 years) and 20% in adolescence (12-18 years). Lymphoedema (27.3%) and dysmorphic features (27.3%) were the main signs that triggered screening in infancy. Short stature was the commonest presenting feature in both childhood (52.8%) and adolescent (38.5%) years. At least 12% of girls fulfilled the criteria for earlier screening but were diagnosed only at a later age (mean age = 8.78 years). 13.4% of patients had classical 45XO karyotype and 52.3% of girls had a variant karyotype.

CONCLUSION:

Majority of girls with TS were diagnosed only after the age of 5 years. Short stature triggered evaluation for most patients diagnosed in childhood and adolescence. Lack of dedicated community height-screening programme to identify children with short stature and lack of awareness could have led to potential delays in diagnosing TS. New strategies for earlier detection of TS are needed.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Idioma: En Revista: Int J Pediatr Endocrinol Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Idioma: En Revista: Int J Pediatr Endocrinol Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido